Cargando…
Controversy regarding ACE inhibitors / ARBs in COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedad Española de Cardiología. Published by Elsevier España, S.L.U.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158842/ https://www.ncbi.nlm.nih.gov/pubmed/32371022 http://dx.doi.org/10.1016/j.rec.2020.04.004 |
| _version_ | 1783522567551713280 |
|---|---|
| author | Soria Arcos, Federico Romero Puche, Antonio Vicente Vera, Tomás |
| author_facet | Soria Arcos, Federico Romero Puche, Antonio Vicente Vera, Tomás |
| author_sort | Soria Arcos, Federico |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7158842 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71588422020-04-15 Controversy regarding ACE inhibitors / ARBs in COVID-19 Soria Arcos, Federico Romero Puche, Antonio Vicente Vera, Tomás Rev Esp Cardiol (Engl Ed) Article Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. 2020-06 2020-04-15 /pmc/articles/PMC7158842/ /pubmed/32371022 http://dx.doi.org/10.1016/j.rec.2020.04.004 Text en © 2020 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Soria Arcos, Federico Romero Puche, Antonio Vicente Vera, Tomás Controversy regarding ACE inhibitors / ARBs in COVID-19 |
| title | Controversy regarding ACE inhibitors / ARBs in COVID-19 |
| title_full | Controversy regarding ACE inhibitors / ARBs in COVID-19 |
| title_fullStr | Controversy regarding ACE inhibitors / ARBs in COVID-19 |
| title_full_unstemmed | Controversy regarding ACE inhibitors / ARBs in COVID-19 |
| title_short | Controversy regarding ACE inhibitors / ARBs in COVID-19 |
| title_sort | controversy regarding ace inhibitors / arbs in covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158842/ https://www.ncbi.nlm.nih.gov/pubmed/32371022 http://dx.doi.org/10.1016/j.rec.2020.04.004 |
| work_keys_str_mv | AT soriaarcosfederico controversyregardingaceinhibitorsarbsincovid19 AT romeropucheantonio controversyregardingaceinhibitorsarbsincovid19 AT vicenteveratomas controversyregardingaceinhibitorsarbsincovid19 |